ASX - By Stock
|
HMD |
Re:
Ann: HeraCARE Platform Records Highest Number of Active Mums
|
|
Level2
|
9 |
2.5K |
12 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
9
|
2.5K
|
12
|
|
ASX - By Stock
|
PL3 |
Re:
Ann: Exceptional Results Achieved from Well Two at Formentera
|
|
Level2
|
13 |
4.3K |
1 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
13
|
4.3K
|
1
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Binding Strategic Partnership Agreement signed US FemBridge
|
|
Level2
|
25 |
5.9K |
0 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
25
|
5.9K
|
0
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Osteopore secures Singapore and Vietnam market approvals
|
|
Level2
|
49 |
22K |
0 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
49
|
22K
|
0
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Prospectus for Renounceable Rights Issue
|
|
Level2
|
45 |
18K |
0 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
45
|
18K
|
0
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Binding Strategic Partnership Agreement signed US FemBridge
|
|
Level2
|
25 |
5.9K |
0 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
25
|
5.9K
|
0
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Trading Halt
|
|
Level2
|
40 |
10K |
1 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
40
|
10K
|
1
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Suspension from Official Quotation
|
|
Level2
|
6 |
1.9K |
4 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
6
|
1.9K
|
4
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Suspension from Official Quotation
|
|
Level2
|
6 |
1.9K |
2 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
6
|
1.9K
|
2
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Despatch of Rights Issue Offer Materials
|
|
Level2
|
20 |
3.1K |
0 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
20
|
3.1K
|
0
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Trading Halt
|
|
Level2
|
19 |
4.3K |
0 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
19
|
4.3K
|
0
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Clinical Trial launched at Gold Coast Hospital
|
|
Level2
|
23 |
3.7K |
4 |
15/11/23 |
15/11/23 |
ASX - By Stock
|
23
|
3.7K
|
4
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Notification regarding unquoted securities - HMD
|
|
Level2
|
52 |
9.1K |
0 |
20/10/23 |
20/10/23 |
ASX - By Stock
|
52
|
9.1K
|
0
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Notice of General Meeting/Proxy Form
|
|
Level2
|
50 |
11K |
7 |
03/10/23 |
03/10/23 |
ASX - By Stock
|
50
|
11K
|
7
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Notice of General Meeting/Proxy Form
|
|
Level2
|
50 |
11K |
3 |
25/09/23 |
25/09/23 |
ASX - By Stock
|
50
|
11K
|
3
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Notice of General Meeting/Proxy Form
|
|
Level2
|
50 |
11K |
2 |
19/09/23 |
19/09/23 |
ASX - By Stock
|
50
|
11K
|
2
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Appendix 4D and Half Year Report
|
|
Level2
|
160 |
27K |
6 |
18/09/23 |
18/09/23 |
ASX - By Stock
|
160
|
27K
|
6
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Appendix 4D and Half Year Report
|
|
Level2
|
160 |
27K |
2 |
06/09/23 |
06/09/23 |
ASX - By Stock
|
160
|
27K
|
2
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Appendix 4D and Half Year Report
|
|
Level2
|
160 |
27K |
4 |
29/08/23 |
29/08/23 |
ASX - By Stock
|
160
|
27K
|
4
|
|
ASX - By Stock
|
HMD |
Re:
Ann: New Appointments to Strengthen USA Commercialisation
|
|
Level2
|
51 |
9.7K |
2 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
51
|
9.7K
|
2
|
|
ASX - By Stock
|
HMD |
Re:
Ann: New Appointments to Strengthen USA Commercialisation
|
|
Level2
|
51 |
9.7K |
0 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
51
|
9.7K
|
0
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Trading Halt
|
|
Level2
|
58 |
12K |
0 |
11/07/23 |
11/07/23 |
ASX - By Stock
|
58
|
12K
|
0
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Trading Halt
|
|
Level2
|
58 |
12K |
1 |
11/07/23 |
11/07/23 |
ASX - By Stock
|
58
|
12K
|
1
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Trading Halt
|
|
Level2
|
58 |
12K |
1 |
10/07/23 |
10/07/23 |
ASX - By Stock
|
58
|
12K
|
1
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Trading Halt
|
|
Level2
|
58 |
12K |
0 |
10/07/23 |
10/07/23 |
ASX - By Stock
|
58
|
12K
|
0
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Trading Halt
|
|
Level2
|
58 |
12K |
2 |
10/07/23 |
10/07/23 |
ASX - By Stock
|
58
|
12K
|
2
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Trading Halt
|
|
Level2
|
58 |
12K |
7 |
10/07/23 |
10/07/23 |
ASX - By Stock
|
58
|
12K
|
7
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Trading Halt
|
|
Level2
|
58 |
12K |
1 |
10/07/23 |
10/07/23 |
ASX - By Stock
|
58
|
12K
|
1
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Trading Halt
|
|
Level2
|
58 |
12K |
1 |
10/07/23 |
10/07/23 |
ASX - By Stock
|
58
|
12K
|
1
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Dr Ron Weinberger appointed Executive Chairman
|
|
Level2
|
44 |
9.3K |
4 |
07/07/23 |
07/07/23 |
ASX - By Stock
|
44
|
9.3K
|
4
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Dr Ron Weinberger appointed Executive Chairman
|
|
Level2
|
44 |
9.3K |
2 |
05/07/23 |
05/07/23 |
ASX - By Stock
|
44
|
9.3K
|
2
|
|
Charts
|
HMD |
Re:
HMD Chart
|
|
Level2
|
677 |
182K |
1 |
04/07/23 |
04/07/23 |
Charts
|
677
|
182K
|
1
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Dr Ron Weinberger appointed Executive Chairman
|
|
Level2
|
44 |
9.3K |
4 |
03/07/23 |
03/07/23 |
ASX - By Stock
|
44
|
9.3K
|
4
|
|
ASX - By Stock
|
HMD |
Re:
Ann: E-Lovu signs first 3 year commercial agreement
|
|
Level2
|
57 |
12K |
1 |
26/06/23 |
26/06/23 |
ASX - By Stock
|
57
|
12K
|
1
|
|
Charts
|
HMD |
Re:
HMD Chart
|
|
Level2
|
677 |
182K |
3 |
20/06/23 |
20/06/23 |
Charts
|
677
|
182K
|
3
|
|
Charts
|
HMD |
Re:
HMD Chart
|
|
Level2
|
677 |
182K |
3 |
14/06/23 |
14/06/23 |
Charts
|
677
|
182K
|
3
|
|
Charts
|
HMD |
Re:
HMD Chart
|
|
Level2
|
677 |
182K |
2 |
14/06/23 |
14/06/23 |
Charts
|
677
|
182K
|
2
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Further information - Strategic Partnership Rewards Platform
|
|
Level2
|
50 |
7.8K |
3 |
06/06/23 |
06/06/23 |
ASX - By Stock
|
50
|
7.8K
|
3
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Further information - Strategic Partnership Rewards Platform
|
|
Level2
|
50 |
7.8K |
1 |
06/06/23 |
06/06/23 |
ASX - By Stock
|
50
|
7.8K
|
1
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Trading Halt
|
|
Level2
|
29 |
5.4K |
2 |
06/06/23 |
06/06/23 |
ASX - By Stock
|
29
|
5.4K
|
2
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Strategic Partnership signed - US employee rewards platform
|
|
Level2
|
41 |
7.3K |
0 |
05/06/23 |
05/06/23 |
ASX - By Stock
|
41
|
7.3K
|
0
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Strategic Partnership signed - US employee rewards platform
|
|
Level2
|
41 |
7.3K |
1 |
05/06/23 |
05/06/23 |
ASX - By Stock
|
41
|
7.3K
|
1
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Strategic Partnership signed - US employee rewards platform
|
|
Level2
|
41 |
7.3K |
0 |
05/06/23 |
05/06/23 |
ASX - By Stock
|
41
|
7.3K
|
0
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Contract signed with private Obstetrics & Gynaecology Group
|
|
Level2
|
36 |
8.6K |
3 |
11/05/23 |
11/05/23 |
ASX - By Stock
|
36
|
8.6K
|
3
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Contract signed with private Obstetrics & Gynaecology Group
|
|
Level2
|
36 |
8.6K |
10 |
11/05/23 |
11/05/23 |
ASX - By Stock
|
36
|
8.6K
|
10
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Quarterly Activities & Cashflow Report
|
|
Level2
|
55 |
11K |
5 |
01/05/23 |
01/05/23 |
ASX - By Stock
|
55
|
11K
|
5
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Board & Management changes
|
|
Level2
|
17 |
3.9K |
5 |
21/04/23 |
21/04/23 |
ASX - By Stock
|
17
|
3.9K
|
5
|
|
ASX - By Stock
|
HMD |
Re:
Quarterly
|
|
Level2
|
35 |
8.4K |
3 |
04/04/23 |
04/04/23 |
ASX - By Stock
|
35
|
8.4K
|
3
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Gold Coast Hospital to begin trial of the HeraCARE Platform
|
|
Level2
|
56 |
13K |
1 |
28/03/23 |
28/03/23 |
ASX - By Stock
|
56
|
13K
|
1
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Change of Director's Interest Notice
|
|
Level2
|
7 |
2.0K |
0 |
27/03/23 |
27/03/23 |
ASX - By Stock
|
7
|
2.0K
|
0
|
|